FM
Frazier Management Portfolio holdings
AUM
$1.12M
This Quarter Return
+128.37%
1 Year Return
+150.24%
3 Year Return
+430.4%
5 Year Return
+1,926.83%
10 Year Return
–
AUM
$204M
AUM Growth
+$204M
(+63%)
Cap. Flow
-$15.4M
Cap. Flow
% of AUM
-7.57%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
1
Reduced
1
Closed
1
Top Buys
| 1 |
Iovance Biotherapeutics
IOVA
|
$10.8M |
Top Sells
| 1 |
Glaukos
GKOS
|
$25.3M |
| 2 |
Amicus Therapeutics
FOLD
|
$929K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TBRA
1
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
| $106M | 52.04% | 2,668,570 | – | – |
|
2
Collegium Pharmaceutical
COLL
$1.22B
| $36.4M | 17.84% | 1,887,332 | – | – |
|
|
3
Amicus Therapeutics
FOLD
$2.34B
| $19.2M | 9.44% | 2,600,014 -125,577 | -5% | -$929K |
|
|
4
Iovance Biotherapeutics
IOVA
$807M
| $17.2M | 8.43% | 2,087,281 +1,312,561 | +169% | +$10.8M |
|
5
Cidara Therapeutics
CDTX
$1.66B
| $15M | 7.37% | 1,312,258 | – | – |
|
|
RXDX
6
DELISTED
Ignyta, Inc.
RXDX
| $5.98M | 2.93% | 950,366 | – | – |
|
|
SRRA
7
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $3.98M | 1.95% | 2,186,195 | – | – |
|
|
8
Glaukos
GKOS
$5.5B
| – | – | -867,788 | Closed | -$25.3M |
|